To determine the molecular basis underlying BCBM, we performed Gene Set Enrichment Analysis (GSEA) on microarray data with human BCBM tumors versus primary breast tumors (26) and identified TBK1 signature as an important pathway enriched in BCBM tumors (Fig. 1A). This evidence concerns the gene TBK1 and breast neoplasm.